Cancer Second Opinion

Massive Bio’s number one priority is to create positive outcomes for cancer patients. With the Clinical Trial Matching Service and Virtual Tumor Board, you are one-step closer to reaching that positive outcome. The Virtual Tumor Board provides you with a team of cancer specialists from the world’s largest cancer research centers.

Cancer clinical trials are important for cancer treatment; they find and prove new ways to fight cancer. By participating in a clinical trial, you can find the best treatment for your or your loved one and help others who may be struggling with cancer. Our team of experts that forms the Virtual Tumor Board use our Artificial Intelligence-based platform, along with their expert oncologist opinions, to provide unique clinical trial options to your specific case.

Getting access to the right clinical trials and right treatments shouldn’t have to be overwhelming. That’s why Massive Bio uses the clinical trial matching service to match cancer patients to the right clinical trials based on the stage of disease, biomarker status, geographical location and past medical history.

Virtual Tumor Board

Virtual Tumor Board

We bring the expertise to you. Your Virtual Tumor Board is comprised of 3 or more physicians who gather and review all your medical history to …

Read more
What is a Second Opinion?

What is a Second Opinion?

Gone are the days of the traditional second opinion.   At Massive Bio, we’re not interested in only 2 opinions. We want expert recommendations …

Read more
Cancer 2nd Opinion

Become a Patient

Massive Bio offers one-of-a-kind, evidence-based services …

Cancer 2nd Opinion

Get a Free Expert Consultation

Why Start Your Journey With Massive Bio? Massive Bio offers …

Cancer 2nd Opinion

Second Opinion

Why …

Cancer 2nd Opinion

See Our Oncologist Network

Would you like to know Massive Bio's network of oncologists? Massive …

Download on the App Store ®Get it on Google Play

Why Get A Virtual Tumor Board?

Our Virtual Tumor Board (VTB) is composed of a team of 3 or more physicians who review your case and medical history in order to offer an expert analysis for treatment options.

Our VTB is also backed with our SYNERGY Artificial Intelligence (AI) platform that has access to over 30,000 active clinical trials and to the latest information available in order to provide the most personalized treatment possible. Our team’s priority is to provide you with a positive outcome.

 

Do You Have Any Questions?

  • Be one step closer to unlocking cancer treatment options.
  • A second opinion without leaving home by US oncologists.
  • Explore options for therapy when you have relapsed or current therapy has failed.
  • Access to clinical trials & immunotherapy options where appropriate.

    By submitting, you agree to our Terms And Conditions and have read and acknowledged our Privacy Statement.

    Contact Us to Help You

    Get a Free Expert Consultation
    11 May 2021

    Clinical Trials for TP53 Wild Type Tumors
    Clinical Trials for TP53 Wild Type Tumors: TP53 is dysregulated in a majority of human solid and hematological tumors. TP53 directly or indirectly regulates multiple cellular functions including cell cycle, apoptosis, DNA repair, and cellular senescence. TP53 dysregulation can generally be attributed to two factors: Somatic or germline mutations of TP53 Excessive negative regulation of wild type TP53 by MDM2/MDM4 genes What is the TP53 Mutation? Over 50% of tumors have mutations in TP53 which leads to the loss of tumor suppressor function of the protein leaving the cell more vulnerable to physiological stresses leading to tumorigenesis. Several pharmaceutical companies are investigating small molecules that restore the function of TP53 to overcome loss of function mutations; these clinical trials are…
    Clinical Trials for TP53 Wild Type Tumors
    Myelofibrosis Symptoms
    27 Feb 2021

    Myelofibrosis Symptoms
    How to understand Myelofibrosis Symptoms? Myelofibrosis is an uncommon type of bone marrow cancer that disrupts your body's normal production of blood cells. This disease occurs when bone marrow stem cells develop mutations in their DNA and affects approximately 1.5 cases per 100,000 people. The end outcome is usually an overproduction of blood cells from a malfunctioning spleen or a lack of red blood cells, which causes anemia. Patients may identify a range of myelofibrosis symptoms, from mild to severe, as a result of the normally spongy bone marrow becoming thick and scarred. Are Myelofibrosis Symptoms associated with other bone marrow diseases? Myelofibrosis is called primary myelofibrosis when it develops on its own and not as a result of another…

    Testimonials

    Next Previous

    "The initial report and clinical trial recommendations was excellent.” So far, my experience with Massive Bio has been very positive. My initial interaction was informative and I was provided with the proper forms to be completed. The initial report and clinical trial recommendations was excellent. The report provided a details summary of my complete cancer medical history including test results, chemotherapy treatments (which revealed an error in the history on file at one medical institution), and procedures. My follow up conversation was professional, informative and educational. She spent a lot of time with me reviewing the clinical trial options, answering my questions on my current chemotherapy treatment regiment, and was proactive regarding follow up and next steps. I look forward to working with Massive Bio on my current cancer journey and hope that they can assist me with combatting and winning this battle.

    Michael L.

    "I have the confidence of knowing that my plan is based on the most current science as it applies to my cancer type." My experience with Massive Bio was professional and satisfying. As a stage 4 cancer patient seeking a second opinion and treatment plan due to recurrence of a stomach tumor, I did not have time to lose negotiating the customary hurdles of my HMO insurance plan. I needed to quickly get opinions of recognized leaders in the field. The concept of a Virtual Tumor Board with quality doctors and health care professionals affiliated with Massive Bio was appealing. I was convinced this approach was worth a try...and I was not disappointed. After meticulously collecting details about past diagnoses, treatments, and tests, a thorough report was submitted to both me and my primary oncologist within days. The treatment plan prioritized strategies and reviewed clinical trials appropriate to my case. The plan was so thorough, well conceptualized, and clearly written that my oncologist and I had only a few questions. Those that we did raise were answered quickly and concisely.

    Steve W.

    "Massive Bio gave my mother and our family a new lease on hope and time." Dealing with a cancer, where all the standard options are limited, Massive Bio helped make the case for new immunotherapy which was selected specifically based on my my mother’s treatment challenges. When our oncologist left, Massive Bio took us that much further.

    Lisa B.

    "There is absolutely no need to look for another expert service in cancer treatment advisory other than Massive Bio." The service Massive Bio provides is very special, going beyond other oncology services. They combine second opinion and precision oncology, taking into consideration patients’ requests and previous treatments. They provide reports from US-based physicians within a week; the diagnosis and treatment suggestions their doctors and team recommend are really personalized and sophisticated. I wish every cancer patient could get an evaluation from Massive Bio. There is absolutely no need to look for another expert service in cancer treatment advisory other than Massive Bio. I congratulate the team that now provides new opportunities for cancer patients.

    Fuat Abut

    "Massive Bio was quick and insightful in finding me the best clinical trial option." Massive Bio worked in collaboration with my local treating oncologist to analyze my carcinoma based on my personal cancer treatment information. In one week, Massive Bio's Virtual Tumor Board experts provided valuable insight and an informative medical report to my doctor. Collaboratively, we agreed that the clinical trial Massive Bio identified was the best option to move ahead. Rating: 1 stars

    Kelly R.

    Frequently Asked Questions